Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Golden. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Golden at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This phase III trial compares the effect of adding cetuximab to pembrolizumab versus pembrolizumab alone in treating patients with head and neck squamous cell carcinoma (HNSCC) that has come back after a period of improvement (recurrent) and/or that has spread from where it first started (primary site) to other places in the body (metastatic). Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this head and neck cancer clinical trial in Golden, CO
If you're searching for head and neck cancer treatment options in Golden, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Golden research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.